Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909440 · ClinicalTrials.gov registry record · NA
Resistance Training and Protein Supplementation for Prostate Cancer Survivors
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT01909440 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 43 participants.
The verdict
NCT01909440, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies resistance training and protein supplementation in increasing lean body mass in patients with prostate cancer receiving androgen deprivation therapy. Resistance training and protein supplementation may help improve quality of life in patients with prostate cancer receiving androgen deprivation therapy.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER pharmacological study
- BEHAVIORAL exercise intervention
- DIETARY_SUPPLEMENT nutritional supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2013-07-08 |
| Est. Completion | 2018-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909440
The ClinicalTrials.gov registry entry for NCT01909440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01909440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01909440 about?
NCT01909440 is a clinical study titled "Resistance Training and Protein Supplementation for Prostate Cancer Survivors". This randomized pilot clinical trial studies resistance training and protein supplementation in increasing lean body mass in patients with prostate cancer receiving androgen deprivation therapy. Resistance training and protein supplementation may help improve quality of life in patients with prostat...
What is the current status of trial NCT01909440?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2013-07-08. Estimated completion is 2018-08-07.
What interventions are being tested in trial NCT01909440?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), pharmacological study (OTHER), exercise intervention (BEHAVIORAL), nutritional supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01909440?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.